Diagnostic Imaging in Pregnancy - Assessing the Risk vs Benefit of Ionising Radiation

Value of the Information & Strength of the Argument

The presentation provides valuable, up-to-date information that challenges outdated fears about radiation in pregnancy. It synthesizes evidence from major guidelines and epidemiological studies, offering clear dose thresholds and practical recommendations. The argumentation is solid, logically progressing from basic principles to clinical applications, and is supported by real clinical cases. The speaker effectively balances theoretical risks with benefits, emphasizing that the absolute risks are very small for typical diagnostic doses. However, some points, such as the increased breast cancer risk in pregnancy, are mentioned without detailed evidence, and the presentation is an expert opinion rather than a systematic review.

Scientific Rigor, Source Quality, Title Accuracy

The presentation demonstrates scientific rigor by referencing established guidelines from ACR, ICRP, SPR, and NRPB, and by grounding risk estimates in well-known cohorts like the Lifespan Study and Oxford Survey. The sources are authoritative and appropriate for the topic. The title accurately reflects the content, which is a risk-benefit assessment of ionizing radiation in pregnancy. The talk is well-structured and evidence-based, though it lacks explicit citations for some specific claims, which could be strengthened. Overall, the scientific quality is high, and the title-content alignment is excellent.

The title accurately reflects the content, which focuses on the risk-benefit assessment of ionizing radiation in pregnancy and provides guidance on when imaging is appropriate.

8/10

The presentation is based on established guidelines from major radiological and radiation protection bodies (ACR, ICRP, SPR, NRPB) and references key epidemiological cohorts (LSS, Oxford Survey). It provides a balanced view of risks and benefits, with practical protocols and clinical cases. However, it is a single expert presentation without peer review, and some claims (e.g., breast cancer risk in pregnancy) are presented without detailed citation.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 00:00Introduction by chair Dr Jarrod Zamparini, setting the context and introducing the presenter.
• 02:00Presenter introduces the topic and outlines the central message: imaging should not be withheld solely due to pregnancy.
• 05:00Explanation of radiation basics: types, dose parameters (absorbed, equivalent, effective), and deterministic vs stochastic effects.
• 10:00Discussion of background radiation and historical data from atomic bomb survivors, including the Lifespan Study.
• 15:00Review of fetal dose thresholds and the lack of deterministic effects at doses below 50 mGy, citing ACR and ICRP.
• 20:00Analysis of childhood cancer risk from in utero exposure, referencing Oxford Survey and NRPB risk coefficients.
• 25:00Detailed discussion of imaging modalities: radiography, fluoroscopy, MRI, ultrasound, and CT, with dose optimization strategies.
• 30:00Comparison of CTPA vs VQ scan for pulmonary embolism, including breast dose considerations.
• 35:00Presentation of clinical cases and the algorithm for CT decision-making in pregnancy, plus occupational exposure limits.

• American College of Radiology (ACR) guidelines — Cited for statement that no deterministic fetal effects are expected below 50 mGy.
• International Commission on Radiological Protection (ICRP) — Cited for radiation protection standards and dose limits.
• Society for Pediatric Radiology (SPR) — Cited for statement on deterministic effects.
• National Radiological Protection Board (NRPB) — Cited for risk coefficients for childhood cancer.
• Lifespan Study (RERF) — Cited as a major cohort for radiation risk assessment.
• Oxford Survey of Childhood Cancers — Cited for background risk of childhood cancer.

• ACR-SPR Practice Parameter for Imaging Pregnant or Potentially Pregnant Adolescents and Women with Ionizing Radiation — Supports the statement that imaging should not be withheld based on pregnancy alone.
• ICRP Publication 84 — Provides similar dose thresholds and risk estimates.

• Some studies on childhood cancer risk — The presenter notes that some epidemiological studies report an increased risk of childhood cancer after in utero radiation, with relative risks up to 2.4, while others find no significant association. This reflects ongoing controversy.